Bixiye
P58-23 Medicare Advantage Part B Step Therapy Program Expansion to Include Vyvgart and Ultomiris
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2023
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1081 - 1090 ee natiijooyinka 3563
Macluumaadka Maaliyadda
Bixiye
medicare-si-007-global-surgical-package.pdf
Bixiye
2023 August Bulletins
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2023
Bixiye
QP65-23 New Medical Coding Pattern Education Program
Taariikhda dhaqangalka Barnaamijka: Jul 26, 2023
Bixiye
QP60-23 Commercial Pharmacy Benefit Exclusion for Elfabrio®, Vyjuvek™
Taariikhda dhaqangalka Barnaamijka: Jul 12, 2023
Bixiye
QP61-23 MHCP Pharmacy Benefit Exclusion for Elfabrio®, Epkinly™, and Vyjuvek™
Taariikhda dhaqangalka Barnaamijka: Jul 12, 2023
Bixiye
QP62-23 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2023
Taariikhda dhaqangalka Barnaamijka: Jul 12, 2023
Bixiye
QP63-23 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2023
Taariikhda dhaqangalka Barnaamijka: Jul 12, 2023